Steps and time to process clinical trials at the Cancer Therapy Evaluation Program - Wikidata - wikimedia - TriplyDB

Steps and time to process clinical trials at the Cancer Therapy Evaluation Program

Steps and time to process clinical trials at the Cancer Therapy Evaluation Program

http://www.wikidata.org/entity/Q37157682

about

Achieving sufficient accrual to address the primary endpoint in phase III clinical trials from U.S. Cooperative Oncology Groups Data for cancer comparative effectiveness research: past, present, and future potential.Routine data from hospital information systems can support patient recruitment for clinical studies.Common metrics to assess the efficiency of clinical research.Time spent for activation of non-profit studies in oncology in Italy.Evaluating protocol lifecycle time intervals in HIV/AIDS clinical trials.Harmonization of the practice of independent ethics committees in Italy: project E-submission.A sense of urgency: Evaluating the link between clinical trial development time and the accrual performance of cancer therapy evaluation program (NCI-CTEP) sponsored studies.Phase III clinical trial development: a process of chutes and ladders Integrating utilization-focused evaluation with business process modeling for clinical research improvement Barriers to recruitment of rural patients in cancer clinical trials.Evaluating translational research: a process marker model Sponsors meet scientists to speed pediatric medicines development Developing Common Metrics for the Clinical and Translational Science Awards (CTSAs): Lessons Learned.Therapeutic hypothermia after pediatric cardiac arrest trials: the vanguard phase experience and implications for other trials.Activating clinical trials: a process improvement approach Protocol Development Program: A Novel Approach to Overcoming Barriers to Clinical Research.Modeling the dissemination and uptake of clinical trials results.Cancer drugs in the United States: Justum Pretium--the just price Impact of NCI-mandated scientific review on protocol development and content.Gynecologic oncology group strategies to improve timeliness of publication.Quasi-random reflections on randomized controlled trials and comparative effectiveness research.Building a statewide clinical trials network for cancer care in West Virginia.Cancer research in the United States: dying by a thousand paper cuts.Institutional Scientific Review of Cancer Clinical Research Protocols: A Unique Requirement That Affects Activation Timelines.Barriers to Cancer Clinical Trial Participation Among Saudi Nationals: A Cross-Sectional Study.Time required to start multicentre clinical trials within the Italian Medicine Agency programme of support for independent research.Setting up a clinical trial for a novel disease: a case study of the Doxycycline for the Treatment of Nodding Syndrome Trial - challenges, enablers and lessons learned.Meeting the Challenge: The National Cancer Institute's Central Institutional Review Board for Multi-Site Research.

P2860

Q30413920-6435E64E-17C2-4B1E-872B-D1FA3BBEA4D1 Q30416509-37C66A61-0302-4C1A-98ED-300DC4504E8A Q33546278-3036A4E8-4606-4C8E-8E6C-D406143A61C1 Q33606537-88744551-A1A4-4A6F-B8F6-FA37F5990F74 Q33649785-E5077285-A027-4316-8203-B61A59978A13 Q34145349-D567DDA2-A5C0-48A1-BD79-62D054936EA7 Q34473705-410BCEC8-A0F2-4540-95EC-11D19E229BE6 Q34632541-87549C6E-FA0F-4320-B668-C20F3D91CCC0 Q34680489-FCE6E276-4457-4C13-A6EB-1B8E602075C5 Q34920219-EB33A486-8DDF-4163-9F70-EEAE6D42737A Q34974911-DC48352C-856A-4F4D-A9B9-9D8AAFB9DFDE Q35075195-F33003E9-1496-4B4C-A855-63143FF61BDE Q35695791-985A27FC-BFBD-4E1A-85FD-B0EC7B0A8085 Q36225313-55C58EC2-E4F0-4EBD-B0FD-886D70587180 Q36518953-25883917-5FDD-4DFE-BA55-6F79B4BE33A2 Q36611986-455E86EF-BFF1-4341-9383-573B19CD9A43 Q36709739-8CACD99F-E3CE-4DE5-9482-3E199FBCAFF1 Q37099505-00B3E1C3-EDC3-41DD-ACCD-E906FAED9903 Q37195250-05FF2D23-8976-4FD1-BEF5-3EC8B39062DB Q37429058-1C81BCA0-B4F7-41F3-8141-CA0A6109CBA4 Q38116490-CFF0FE62-91FF-4B48-987A-4DEE83639ACF Q38418042-8D15FD49-5AA3-4C15-8404-7F511B30C018 Q44952552-CD5AC31E-8620-42E1-BE4B-00F86A47C5D5 Q45863241-EB29B189-79B4-401D-B3A5-C0200F9F86EC Q47246598-4076E977-6099-417C-82C9-8C81D97423C1 Q47686048-98336FD9-2720-41D6-9317-250581089B50 Q48033868-592AC79E-35EC-44F8-AC55-4657B5815DAE Q48140145-6A655C78-55CF-485C-B4C5-630D29ED3F2D Q49559109-555F8159-EF90-4E64-AD1F-2CD404C48F0A

P2860

Steps and time to process clinical trials at the Cancer Therapy Evaluation Program

http://www.wikidata.org/entity/Q37157682

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 02 March 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Steps and time to process clinical trials at the Cancer Therapy Evaluation Program

@en

Steps and time to process clinical trials at the Cancer Therapy Evaluation Program.

@nl

type

label

Steps and time to process clinical trials at the Cancer Therapy Evaluation Program

@en

Steps and time to process clinical trials at the Cancer Therapy Evaluation Program.

@nl

prefLabel

Steps and time to process clinical trials at the Cancer Therapy Evaluation Program

@en

Steps and time to process clinical trials at the Cancer Therapy Evaluation Program.

@nl

P1433

Q37157682-6B21141B-62D9-4CD9-BDE8-4E2E476E0CAA

P1476

Q37157682-C8DF8929-4FA4-4CF6-BCEF-C7404CB007F4

P2093

Q37157682-3A13A51C-A729-4853-A80B-D166A610B8F7

Q37157682-4DE9F00D-FF44-447E-A017-DC6E2095AC1D

Q37157682-58928468-01E7-41F4-B7F9-4407A508A253

Q37157682-59760FFD-4685-4AD6-86DD-03EB33704754

Q37157682-793A3BAB-3435-4670-9697-2AFF13A7FB29

Q37157682-7E974EB3-3E37-4C1C-A786-CBED2E8FA43E

Q37157682-85E48748-8DC4-418F-8508-2B867E1C1067

Q37157682-87652723-97C4-4FC5-97DD-2BBA6509C486

Q37157682-917F2305-7E93-4B10-9F06-442FA48E43CC

Q37157682-C8B7E50C-234E-4794-8C38-5FB0418575CC

P2860

Q37157682-023956F9-9DBC-440D-93EB-EBFEEB7BEDBD

Q37157682-4A3D1D7F-1725-4CFF-BAD6-02C654911D96

Q37157682-65005E0A-4FEF-42F1-99C2-944251E40882

Q37157682-65744891-9684-4F0C-8EFB-FC686E28D45C

Q37157682-7D3F3E53-83CF-4AF9-A097-F07C8B07317F

Q37157682-A88CB656-1046-4FCD-B1FD-1A32D90D16AF

Q37157682-BF12C91C-EFAD-410E-AFC9-D4B20458FCD5

P304

Q37157682-14B28BB2-F9E4-44B2-8969-02F44B054136

P31

Q37157682-CBFC7720-EF5B-4BDA-81E0-D5A6D6D17A9B

P356

Q37157682-6BA44312-4D3F-4BD2-B169-AC023AD8B6C8

P407

Q37157682-19627258-D602-4D6C-AD65-6A311DB340D2

P433

Q37157682-05D6A696-BD29-4AD2-ADC6-0369D6776EA9

P478

Q37157682-02DC753D-9455-405A-A3C5-4B774DC442C2

P577

Q37157682-2A9252DA-99C8-403F-93CF-9F0A02339F3B

P698

Q37157682-18108881-75F6-4005-9F1D-EBCCAC1A0D84

P932

Q37157682-E80393FA-7AEC-4A54-8A10-DD9257BD87EE

P356

JCO.2008.19.9133

P1433

Journal of Clinical Oncology

P1476

Steps and time to process clinical trials at the Cancer Therapy Evaluation Program

@en

P2093

Alan B Sandler

http://www.w3.org/2001/XMLSchema#string

Amy Y Wu

http://www.w3.org/2001/XMLSchema#string

David M Dilts

http://www.w3.org/2001/XMLSchema#string

Jeffrey Abrams

http://www.w3.org/2001/XMLSchema#string

Joshua S Crites

http://www.w3.org/2001/XMLSchema#string

Lori B Ferranti

http://www.w3.org/2001/XMLSchema#string

Margaret Mooney

http://www.w3.org/2001/XMLSchema#string

Shanda Finnigan

http://www.w3.org/2001/XMLSchema#string

Steven Friedman

http://www.w3.org/2001/XMLSchema#string

Steven K Cheng

http://www.w3.org/2001/XMLSchema#string

P2860

Academic medical centers' standards for clinical-trial agreements with industry.

Invisible barriers to clinical trials: the impact of structural, infrastructural, and procedural barriers to opening oncology clinical trials.

Development of clinical trials in a cooperative group setting: the eastern cooperative oncology group

Processes to activate phase III clinical trials in a Cooperative Oncology Group: the Case of Cancer and Leukemia Group B.

Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment.

The National Cancer Institute audit of the National Surgical Adjuvant Breast and Bowel Project Protocol B-06.

The Cancer Therapy Evaluation Program (CTEP) at the National Cancer Institute: industry collaborations in new agent development.

P304

1761-1766

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2008.19.9133

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P577

2009-03-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19255315

http://www.w3.org/2001/XMLSchema#string

P932

2668703

http://www.w3.org/2001/XMLSchema#string